NCT02534649
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
Registry fields
- Overall status
- RECRUITING
- Conditions
- Solid Tumor, Hematological Malignancy
- Study type
- INTERVENTIONAL
- Phase
- NA
- Primary purpose
- DIAGNOSTIC
- Intervention type
- PROCEDURE
- Interventions
- Newly obtained biopsy and Blood samples collection
- Lead sponsor
- Institut Bergonié (OTHER)
Cached at: 2026-10-09 01:26:55
Brief summary
This is a biology driven, monocentric study designed to identify actionable molecular alterations in cancer patients with advanced disease.
In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling.
Patients included in the BIP study and for whom a targetable genomic alteration had been identified might be subsequently included in an early phase trials running at Institut Bergonie or another French hospital.
In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling.
Patients included in the BIP study and for whom a targetable genomic alteration had been identified might be subsequently included in an early phase trials running at Institut Bergonie or another French hospital.
Contact
Need a report or Korean medical writing based on this trial?
Sign in with Kakao to continue